Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hacker

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 7, 2014
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumoursMartin R Weihrauch, Heike Richly, Michael S von Bergwelt-Baildon, et al.
British Journal of Cancer|October 7, 2010
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapyV Goede, O Coutelle, J Neuneier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 29, 2014
Tropism-modified AAV vectors overcome barriers to successful cutaneous therapyJessica Sallach, Giovanni Di Pasquale, Fernando Larcher, et al.
The Journal of Gene Medicine|June 10, 2005
Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyUlrich T Hacker, Lisa Wingenfeld, David M Kofler, et al.
Cell Reports|March 19, 2013
Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXAKerstin Brinkmann, Paola Zigrino, Axel Witt, et al.
Hepatology (Baltimore, Md.)|March 21, 2017
Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectorsMarianna Hösel, Anke Huber, Susanne Bohlen, et al.
Human Gene Therapy|August 14, 2019
Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial CellsL Zhang, A Rossi, L Lange, et al.
JCO Precision Oncology|May 31, 2024
Exceptional Response of <i>BRAF</i><sup>V600E</sup>-Mutated Acinar Cell CUP to BRAF/MEK InhibitionIrina A Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2026
FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinomaDavid Tougeron, Fernando Rivera, Tania Fleitas Kanonnikoff, et al.
EMBO Molecular Medicine|March 21, 2014
Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healingOliver Coutelle, Hue-Tran Hornig-Do, Axel Witt, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|December 7, 2014
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumoursMartin R Weihrauch, Heike Richly, Michael S von Bergwelt-Baildon, et al.
British Journal of Cancer|October 7, 2010
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapyV Goede, O Coutelle, J Neuneier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 29, 2014
Tropism-modified AAV vectors overcome barriers to successful cutaneous therapyJessica Sallach, Giovanni Di Pasquale, Fernando Larcher, et al.
The Journal of Gene Medicine|June 10, 2005
Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyUlrich T Hacker, Lisa Wingenfeld, David M Kofler, et al.
Cell Reports|March 19, 2013
Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXAKerstin Brinkmann, Paola Zigrino, Axel Witt, et al.
Hepatology (Baltimore, Md.)|March 21, 2017
Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectorsMarianna Hösel, Anke Huber, Susanne Bohlen, et al.
Human Gene Therapy|August 14, 2019
Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial CellsL Zhang, A Rossi, L Lange, et al.
JCO Precision Oncology|May 31, 2024
Exceptional Response of <i>BRAF</i><sup>V600E</sup>-Mutated Acinar Cell CUP to BRAF/MEK InhibitionIrina A Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2026
FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinomaDavid Tougeron, Fernando Rivera, Tania Fleitas Kanonnikoff, et al.
EMBO Molecular Medicine|March 21, 2014
Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healingOliver Coutelle, Hue-Tran Hornig-Do, Axel Witt, et al.
Pageof 7